{
    "info": {
        "nct_id": "NCT03685708",
        "official_title": "Response to the HEPLISAV-B Hepatitis B Vaccine in Treatment Naive Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's -Tyrosine Kinase Inhibitor (BTK-I)",
        "inclusion_criteria": "* INCLUSION CRITERIA:\n* Diagnosis of CLL/SLL which is made according to the updated criteria of the NCI Working Group.\n* No known active or past hepatitis B infection\n* No history of prior hepatitis B virus vaccination (approved or investigational)\n* History of negative hepatitis B viral titers (negative HBsAg, HBsAb and HBcAb)\n* Cohort 1: Treatment naive CLL patients\n* Cohort 2: Subjects must be receiving ibrutinib monotherapy for at least 6 months prior to administration of the first vaccine dose\n* Cohort 3: Subjects must be receiving acalabrutinib monotherapy for at least 6 months prior to administration of the first vaccine dose\n* Age greater than or equal to 18 years.\n* ECOG performance status of 0-1\n* Able to comprehend the investigational nature of the protocol and provide informed consent.\n\nEXCLUSION CRITERIA:\n\n* Female patients who are currently pregnant.\n* Any uncontrolled active systemic infection\n* Any life-threatening illness, medical condition, or organ system dysfunction that, in the investigator s opinion, could compromise the subject s safety or put the study outcomes at undue risk\n* History of severe allergic reaction to any component of HEPLISAV-B, including yeast\n* Receive intravenous or subcutaneous immunoglobulin (IVIG) within 3 months prior to vaccination\n* Concomitant use of immunosuppressive agents (e.g. steroids, radiotherapy, chemotherapy)\n* Hereditary or acquired immunodeficiency syndrome unrelated to CLL\n* Non-English speaking individuals will be excluded from the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Receive intravenous or subcutaneous immunoglobulin (IVIG) within 3 months prior to vaccination",
            "criterions": [
                {
                    "exact_snippets": "Receive intravenous or subcutaneous immunoglobulin (IVIG) within 3 months prior to vaccination",
                    "criterion": "immunoglobulin (IVIG) administration",
                    "requirements": [
                        {
                            "requirement_type": "route",
                            "expected_value": [
                                "intravenous",
                                "subcutaneous"
                            ]
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months prior to vaccination"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Concomitant use of immunosuppressive agents (e.g. steroids, radiotherapy, chemotherapy)",
            "criterions": [
                {
                    "exact_snippets": "Concomitant use of immunosuppressive agents (e.g. steroids, radiotherapy, chemotherapy)",
                    "criterion": "immunosuppressive agent use",
                    "requirements": [
                        {
                            "requirement_type": "concomitant use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Non-English speaking individuals will be excluded from the study",
            "criterions": [
                {
                    "exact_snippets": "Non-English speaking individuals will be excluded",
                    "criterion": "English language proficiency",
                    "requirements": [
                        {
                            "requirement_type": "proficiency",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status of 0-1",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cohort 2: Subjects must be receiving ibrutinib monotherapy for at least 6 months prior to administration of the first vaccine dose",
            "criterions": [
                {
                    "exact_snippets": "Subjects must be receiving ibrutinib monotherapy",
                    "criterion": "ibrutinib monotherapy",
                    "requirements": [
                        {
                            "requirement_type": "current treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "for at least 6 months prior to administration of the first vaccine dose",
                    "criterion": "duration of ibrutinib monotherapy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of CLL/SLL which is made according to the updated criteria of the NCI Working Group.",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of CLL/SLL",
                    "criterion": "CLL/SLL diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "according to the updated criteria of the NCI Working Group",
                    "criterion": "diagnosis criteria (NCI Working Group)",
                    "requirements": [
                        {
                            "requirement_type": "diagnostic standard",
                            "expected_value": "updated criteria of the NCI Working Group"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of severe allergic reaction to any component of HEPLISAV-B, including yeast",
            "criterions": [
                {
                    "exact_snippets": "History of severe allergic reaction to any component of HEPLISAV-B",
                    "criterion": "severe allergic reaction to any component of HEPLISAV-B",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including yeast",
                    "criterion": "severe allergic reaction to yeast",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cohort 3: Subjects must be receiving acalabrutinib monotherapy for at least 6 months prior to administration of the first vaccine dose",
            "criterions": [
                {
                    "exact_snippets": "Subjects must be receiving acalabrutinib monotherapy",
                    "criterion": "acalabrutinib monotherapy",
                    "requirements": [
                        {
                            "requirement_type": "treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "for at least 6 months prior to administration of the first vaccine dose",
                    "criterion": "duration of acalabrutinib monotherapy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any uncontrolled active systemic infection",
            "criterions": [
                {
                    "exact_snippets": "Any uncontrolled active systemic infection",
                    "criterion": "systemic infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age greater than or equal to 18 years.",
            "criterions": [
                {
                    "exact_snippets": "Age greater than or equal to 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 99 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 99 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 99,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cohort 1: Treatment naive CLL patients",
            "criterions": [
                {
                    "exact_snippets": "Treatment naive CLL patients",
                    "criterion": "chronic lymphocytic leukemia (CLL) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Treatment naive",
                    "criterion": "prior treatment for CLL",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hereditary or acquired immunodeficiency syndrome unrelated to CLL",
            "criterions": [
                {
                    "exact_snippets": "Hereditary or acquired immunodeficiency syndrome",
                    "criterion": "immunodeficiency syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "hereditary",
                                "acquired"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "unrelated to CLL",
                    "criterion": "relation of immunodeficiency syndrome to CLL",
                    "requirements": [
                        {
                            "requirement_type": "relation",
                            "expected_value": "unrelated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No known active or past hepatitis B infection",
            "criterions": [
                {
                    "exact_snippets": "No known active or past hepatitis B infection",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "current_status",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Able to comprehend the investigational nature of the protocol and provide informed consent.",
            "criterions": [
                {
                    "exact_snippets": "Able to comprehend the investigational nature of the protocol",
                    "criterion": "comprehension of investigational nature of the protocol",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "provide informed consent",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any life-threatening illness, medical condition, or organ system dysfunction that, in the investigator s opinion, could compromise the subject s safety or put the study outcomes at undue risk",
            "criterions": [
                {
                    "exact_snippets": "Any life-threatening illness, medical condition, or organ system dysfunction",
                    "criterion": "life-threatening illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Any life-threatening illness, medical condition, or organ system dysfunction",
                    "criterion": "medical condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Any life-threatening illness, medical condition, or organ system dysfunction",
                    "criterion": "organ system dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "that, in the investigator s opinion, could compromise the subject s safety or put the study outcomes at undue risk",
                    "criterion": "investigator's opinion of risk",
                    "requirements": [
                        {
                            "requirement_type": "risk assessment",
                            "expected_value": "could compromise subject's safety or put study outcomes at undue risk"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No history of prior hepatitis B virus vaccination (approved or investigational)",
            "criterions": [
                {
                    "exact_snippets": "No history of prior hepatitis B virus vaccination (approved or investigational)",
                    "criterion": "hepatitis B virus vaccination",
                    "requirements": [
                        {
                            "requirement_type": "history of vaccination",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female patients who are currently pregnant.",
            "criterions": [
                {
                    "exact_snippets": "Female patients",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "currently pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "current status",
                            "expected_value": "pregnant"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of negative hepatitis B viral titers (negative HBsAg, HBsAb and HBcAb)",
            "criterions": [
                {
                    "exact_snippets": "negative hepatitis B viral titers (negative HBsAg, HBsAb and HBcAb)",
                    "criterion": "hepatitis B surface antigen (HBsAg)",
                    "requirements": [
                        {
                            "requirement_type": "titer status",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "negative hepatitis B viral titers (negative HBsAg, HBsAb and HBcAb)",
                    "criterion": "hepatitis B surface antibody (HBsAb)",
                    "requirements": [
                        {
                            "requirement_type": "titer status",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "negative hepatitis B viral titers (negative HBsAg, HBsAb and HBcAb)",
                    "criterion": "hepatitis B core antibody (HBcAb)",
                    "requirements": [
                        {
                            "requirement_type": "titer status",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "* INCLUSION CRITERIA:",
            "criterions": []
        },
        {
            "line": "EXCLUSION CRITERIA:",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}